KR20180039464A - Gluten-free noodle composition containing transglutaminase - Google Patents
Gluten-free noodle composition containing transglutaminase Download PDFInfo
- Publication number
- KR20180039464A KR20180039464A KR1020160130803A KR20160130803A KR20180039464A KR 20180039464 A KR20180039464 A KR 20180039464A KR 1020160130803 A KR1020160130803 A KR 1020160130803A KR 20160130803 A KR20160130803 A KR 20160130803A KR 20180039464 A KR20180039464 A KR 20180039464A
- Authority
- KR
- South Korea
- Prior art keywords
- gluten
- transglutaminase
- present
- lactic acid
- free
- Prior art date
Links
- 108060008539 Transglutaminase Proteins 0.000 title claims abstract description 20
- 102000003601 transglutaminase Human genes 0.000 title claims abstract description 20
- 239000000203 mixture Substances 0.000 title abstract description 16
- 235000012149 noodles Nutrition 0.000 title abstract description 14
- 108010068370 Glutens Proteins 0.000 claims abstract description 41
- 235000021312 gluten Nutrition 0.000 claims abstract description 40
- 239000012228 culture supernatant Substances 0.000 claims abstract description 7
- 235000013312 flour Nutrition 0.000 claims abstract description 6
- 241000209140 Triticum Species 0.000 claims abstract description 4
- 235000021307 Triticum Nutrition 0.000 claims abstract description 4
- 229920000881 Modified starch Polymers 0.000 claims abstract description 3
- 239000004368 Modified starch Substances 0.000 claims abstract description 3
- 235000019426 modified starch Nutrition 0.000 claims abstract description 3
- 229920001592 potato starch Polymers 0.000 claims abstract description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 54
- 235000014655 lactic acid Nutrition 0.000 claims description 27
- 239000004310 lactic acid Substances 0.000 claims description 27
- 241000894006 Bacteria Species 0.000 claims description 24
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 230000000704 physical effect Effects 0.000 abstract description 5
- 241000186660 Lactobacillus Species 0.000 abstract description 3
- 229940039696 lactobacillus Drugs 0.000 abstract description 3
- 230000003247 decreasing effect Effects 0.000 abstract description 2
- 230000015556 catabolic process Effects 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 238000006731 degradation reaction Methods 0.000 description 7
- 241000252203 Clupea harengus Species 0.000 description 6
- 229920000742 Cotton Polymers 0.000 description 6
- 229920002907 Guar gum Polymers 0.000 description 6
- 239000000665 guar gum Substances 0.000 description 6
- 235000010417 guar gum Nutrition 0.000 description 6
- 229960002154 guar gum Drugs 0.000 description 6
- 235000019514 herring Nutrition 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 208000015943 Coeliac disease Diseases 0.000 description 5
- 240000006024 Lactobacillus plantarum Species 0.000 description 5
- 238000001125 extrusion Methods 0.000 description 5
- 235000012470 frozen dough Nutrition 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 4
- 229940072205 lactobacillus plantarum Drugs 0.000 description 4
- 241000186000 Bifidobacterium Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 241000238366 Cephalopoda Species 0.000 description 2
- 241001584954 Lactobacillus brevis ATCC 14869 = DSM 20054 Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- -1 pro-amines Chemical class 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- HZWWPUTXBJEENE-UHFFFAOYSA-N 5-amino-2-[[1-[5-amino-2-[[1-[2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid Chemical compound C1CCC(C(=O)NC(CCC(N)=O)C(=O)N2C(CCC2)C(=O)NC(CCC(N)=O)C(O)=O)N1C(=O)C(N)CC1=CC=C(O)C=C1 HZWWPUTXBJEENE-UHFFFAOYSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000186012 Bifidobacterium breve Species 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010061711 Gliadin Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 244000025090 Lactobacillus sanfrancisco Species 0.000 description 1
- 235000013864 Lactobacillus sanfrancisco Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 101710123874 Protein-glutamine gamma-glutamyltransferase Proteins 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 244000082988 Secale cereale Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 241001329985 Triticeae Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 210000005006 adaptive immune system Anatomy 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229940004120 bifidobacterium infantis Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000006481 deamination reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 101150073877 egg-1 gene Proteins 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- ODFAPIRLUPAQCQ-UHFFFAOYSA-M sodium stearoyl lactylate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O ODFAPIRLUPAQCQ-UHFFFAOYSA-M 0.000 description 1
- 239000003724 sodium stearoyl-2-lactylate Substances 0.000 description 1
- 235000010956 sodium stearoyl-2-lactylate Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/109—Types of pasta, e.g. macaroni or noodles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
본 발명은 트랜스글루타미나아제를 포함하는 글루텐 프리형 면 조성물에 대한 것이다.The present invention relates to a gluten-free surface composition comprising transglutaminase.
글루텐은 밀, 보리 및 호밀을 포함하는 밀족(triticeae tribe) 곡물에서 발견되는 단백질 복합체이다. 글루텐 단백질들(글리아딘 및 유사한 프롤아민 및 글루테닌)은 복강 질환 및 다른 관련된 질환을 유발시키는 주요 환경 인자를 나타낸다. 이러한 단백질은 프롤린 및 글루타민에 풍부한 펩티드 서열을 함유하는데, 이는 일반 음식물(diet) 중의 다른 단백질들에 비해 소화 효소에 대해 보다 큰 저항성을 나타내고, 이에 따라 소장강(intestinal lumen)에 잔류할 수 있다. 유전적으로 병에 걸리기 쉬운 개체에서, 이러한 펩티드는 선천성 면역계 및 적응 면역계 둘 모두를 포함하고 포괄적으로 장내 점막의 만성 염증, 상피내 림프구 증가, 선와 증식(crypt hyperplasia), 및 이들의 전체 소멸을 포함하는 장 융모의 진행성 퇴화를 초래하는 이상 반응(anomalousreaction)의 원인이 된다.셀리악병이란 소장에서 일어나는 알레르기 질환으로, 장 내의 영양분 흡수를 저해하는 글루텐에 대한 감수성이 일어남으로써 증세가 나타나는 질병이다. 셀리악병은 유전되는 것으로 알려져 있고, 자가면역 질환이며 모든 연령에서 발병할 수 있다. 대부분 생후 2주의 유아에서부터 1년 정도의 어린이에게서 글루텐 섭취를 시작하면서 나타나며, 드물게는 성인이 된 후에 처음 나타나는 경우도 있다. 따라서, 최근에는 글루텐 프리 식품에 대한 요구가 증가하고 있으며, 글루텐 프리 식품이 건강식품 및 프리미엄 식품이라는 인식이 확산되고 있는 실정이다.Gluten is a protein complex found in triticeae tribe grains, including wheat, barley and rye. Gluten proteins (gliadins and similar pro-amines and glutenines) represent a major environmental factor that induces celiac disease and other related diseases. These proteins contain proline and glutamine rich peptide sequences that are more resistant to digestive enzymes than other proteins in the diet and can therefore remain in the intestinal lumen. In individuals who are genetically susceptible to disease, such peptides include both congenital and adaptive immune systems and are broadly divided into intestinal mucosa chronic inflammation, intracapillary lymphocyte hyperplasia, crypt hyperplasia, Celiac disease is an allergic disease that occurs in the small intestine, which is characterized by the susceptibility to gluten, which inhibits absorption of nutrients in the intestines. Celiac disease is known to be inherited, is an autoimmune disease and can occur at any age. It usually appears as a start of ingestion of gluten from a 2-week-old infant to a 1-year-old child, and rarely appears first after becoming an adult. Therefore, in recent years, there has been an increasing demand for gluten-free foods, and there is a growing awareness that gluten-free foods are health foods and premium foods.
그러나 글루텐이 전혀 없게 되면 밀가루로 면을 제조할 때 네트워크 형성이 어려워서 제대로된 반죽이 형성되지 않아 면을 만들 수 없다.그래서 글루텐의 역할을 대신할 물질을 추가로 첨가하기도 한다.따라서 셀룰로오스 에테르와 같은 물질을 넣어주어서 글루텐의 역할을 대신하도록 하고 있다.However, when gluten is not present at all, it is difficult to form a network when flour is used to make cotton, so it is impossible to make a dough because it does not form a proper dough, so it may be added with a substance that replaces the role of gluten. To replace the role of gluten.
트랜스글루타미나제(transglutaminase, TGase, E.C 2.3.2.1.3)는 단백질들을 교차 결합하는 효소로 동물, 식물, 미생물 등 자연계에 널리 분포되어 있다. 이들 트랜스글루타미나제가 단백질이나 펩타이드에 작용할 경우, 아실 교환반응, 교차반응, 탈아미노 반응 등에 의해서 글루타민(Glutamine)과 리신(Lysine)간의 교차 결합을 형성할 수 있다Transglutaminase (TGase, EC 2.3.2.1.3) is an enzyme that crosslinks proteins and is widely distributed in animals, plants, microorganisms, and the like. When these transglutaminases act on proteins or peptides, they can form cross-linking between glutamine and lysine by acyl exchange, cross-linking, and deamination reactions
본 발명자들은 유산균을 이용하여글루텐 프리 밀가루를 이용하여 면을 제조할 때 글루텐의 감소에 따른 물성을 보충하기 위하여 트랜스글루타미나제를 첨가하고 다단압출방식을 적용하면 종래의 면정도의 물성을 가질 수 있는 것을 확인하고 본 발명을 완성하였다.The present inventors have found that when a gluten-free flour is used to make a surface of a lactic acid bacterium, transglutaminase is added to supplement the physical properties of the gluten, and when a multi-stage extrusion method is applied, And completed the present invention.
본 발명은 유산균 및 트랜스글루타미나아제를 포함하는 글루텐 프리 면을 제공하는 것을 목적으로 한다.It is an object of the present invention to provide a gluten free surface comprising lactic acid bacteria and transglutaminase.
본 발명은 유산균 및 트랜스글루타미나아제를 포함하는 글루텐 프리 면의 제조 방법을 제공하는 것을 목적으로 한다.It is an object of the present invention to provide a process for producing a gluten-free surface comprising lactic acid bacteria and a transglutaminase.
상기한 목적을 위하여 본 발명은 소맥분 40.00내지 45.00중량%, 변성전분 15.00내지 25.00중량%, 감자전분 5.00 내지 10.00중량%, 폴리글리시톨 0.20 내지 0.50 중량%, 트랜스글루타미나아제 0.10 내지 0.50 중량%, 유산균 배양 상등액 10.00 내지 40.00중량%를 포함하는 글루텐 프리 면이다.To achieve the above object, the present invention provides a method for producing a starch, comprising: 40.00 to 45.00% by weight of wheat flour, 15.00 to 25.00% by weight of modified starch, 5.00 to 10.00% by weight of potato starch, 0.20 to 0.50% by weight of polyglycitol, 0.10 to 0.50% % Of lactic acid bacteria culture supernatant, 10.00 to 40.00 wt% of lactic acid bacteria culture supernatant.
본 발명에서 “글루텐 프리 면”의 의미는 종래의 면 제조에 사용되는 글루텐이 포함된 물질을 글루텐이 저감되도록 가공하여 제조된 면을 의미한다.여기에서 “프리”란 완전히 무(zero)의 의미가 아니라 원재료에 포함된 글루텐의 양보다 저감되어 상대적으로 적은 양의 글루텐를 포함하고 있다는 의미이다. The term " gluten-free surface " in the present invention means a surface prepared by processing a gluten-containing material used for conventional surface preparation to reduce gluten. Here, " free " But rather the amount of gluten contained in the raw material is lower than the amount of gluten contained in the raw material.
상기에서 트랜스글루타미나아제의 농도가 0.10 중량%미만인 경우에는 면대 형성이 어렵고, 0.50 중량%를 초과하는 경우에는 탄력성이 떨어지는 문제점이 있다.When the concentration of the transglutaminase is less than 0.10 wt%, it is difficult to form the surface layer, and when the concentration exceeds 0.50 wt%, the elasticity is deteriorated.
바람직하게는 상기 트랜스글루타미나아제의 농도는 0.30 내지 0.40 중량%이고,가장 바람직하게는 0.35 내지 0.37 중량%이다.Preferably, the concentration of the transglutaminase is 0.30 to 0.40% by weight, and most preferably 0.35 to 0.37% by weight.
상기에서 유산균은 글루텐을 분해할 수 있는 유산균은 다양하게 사용될 수 있다.예를 들어 특허출원 10-2015-7015081호에 기재된 락토바실러스 플란타럼 ATCC 8014 (Lactobacillus plantarum ATCC 8014), 락토바실러스 샌프란시센시스 ATCC 27652 (Lactobacillus sanfranciscensis ATCC27652) 및 락토바실러스 브레비스 ATCC 14869 (Lactobacillus brevis ATCC 14869)가 사용될 수 있으나,이에 제한되는 것은 아니다.For example, Lactobacillus plantarum ATCC 8014 described in Patent Application 10-2015-7015081, Lactobacillus plantarum ATCC 8014, system ATCC 27652 (Lactobacillus sanfranciscensis ATCC27652), and Lactobacillus brevis ATCC 14869 (Lactobacillus brevis ATCC 14869), but can be used, without being limited thereto.
유산균의 배양은 다양한 배지를 이용할 수 있다.바람직하게는 면의 맛과 향에 나쁜 영향을 주지 않는 배지를 사용하는 것이 효과적이다.당업자는 본 발명의 요지를 변경하지 않는 범위에서 유산균에 따라 적절한 배지를 선정할 수 있다.바람직하게는 MRS 배지를 사용할 수 있다.A variety of media can be used for the cultivation of the lactic acid bacteria. It is preferable to use a culture medium which does not adversely affect the taste and flavor of the cotton. MRS medium can be used preferably.
유산균의 배양시간은 배지의 조성에 따라 달라질 수 있으나 글루텐의 분해활성이 가장 높은 시간을 선택하여 사용될 수 있다.일반적으로 유산균의 배양시간은 12 내지 48시간의 범위내에서 배양되어질 수 있다.The culture time of the lactic acid bacteria may vary depending on the composition of the culture medium, but may be selected from the time when the gluten degradation activity is highest. In general, the culture time of the lactic acid bacteria may be in the range of 12 to 48 hours.
유산균 배양 상등액은 상기 유산균에 의한 글루텐 활성이 가장 좋을 때의 배양시간을 선택하여 원심분리를 한 후 상등액을 얻어서 사용할 수 있다.The culture supernatant of the lactic acid bacteria can be used after obtaining the supernatant after centrifugation by selecting the incubation time when the gluten activity by the above-mentioned lactic acid bacteria is the best.
유산균 배양 상등액의 양은 10.00 중량%보다 적을 때에는 유산균 배양액에 의한 글루텐의 분해가 적어 글루텐의 감소가 적고,40.00중량%보다 많을 경우에는 유산균 배양액에 의한 맛과 향에 의해 면의 맛과 향이 변질되어질 수 있다.바람직하게는 상기 유산균 배양 상등액은 20.00 내지 30.00 중량%의 양으로 사용될 수 있고,가장 바람직하게는 26.00 내지 28.00중량%로 사용될 수 있다. When the amount of the culture supernatant of lactic acid bacteria is less than 10.00% by weight, the degradation of gluten due to the lactic acid bacteria culture is small and the decrease of gluten is small. When the amount is more than 40.00% by weight, the taste and flavor of the cotton Preferably, the lactic acid bacteria culture supernatant can be used in an amount of 20.00 to 30.00% by weight, and most preferably 26.00 to 28.00% by weight.
본 발명에 따른 면은 종래의 면에 비하여 글루텐의 양이 저감되어서 글루텐에 의한 질환의 위험이 감소된 면이다.본 발명에 따른 면은 글루텐의 감소에 따른 경도,응집성 및 씹힘성에서 종래의 면에 비슷한 정도의 물성을 가지고 있어서 글루텐이 저감되면서도 종래의 면과 같은 맛과 형상을 가지고 있다.The surface according to the present invention is reduced in the amount of gluten compared with the conventional surface, thereby reducing the risk of diseases caused by gluten. The surface according to the present invention has a hardness, cohesiveness and chewiness due to decrease in gluten, It has a similar physical property, so it has the same flavor and shape as the conventional face while reducing gluten.
도 1은 압연 방식으로 제조된 유산균 발효 우동을 보인다.
도 2는 압출 방식으로 제조된 유산균 발효 우동을 보인다. FIG. 1 shows fermented noodles of lactic acid bacteria prepared by the rolling method.
Fig. 2 shows lactic acid fermented noodles produced by the extrusion method.
<< 비교예Comparative Example 1>유산균1> lactic acid bacteria 발효된 반죽을 이용한 면의 제조 Fabrication of cotton using fermented dough
유산균은 청어알 1, 청어알 12, 청어알 25, 낙지 25, BS40꼴뚜기, 꼴뚜기25 로 한국생명공학연구원에서 제공받아 실험을 진행하였다.소맥분,변성전분,감자전분 등을 포함하는 대조구의 면 제조성분의 배합비는 표 1에 나타내었다.The lactic acid bacteria were supplied from Korea Research Institute of Bioscience and Biotechnology with Herring Egg 1, Herring Egg 12, Herring Egg 25, Octopus 25, BS40 Squid, and Squid 25. The blending ratio of the components is shown in Table 1.
대조구, 청어알1, 청어알12, 청어알25 유산균을 첨가하여 만든 우동면의 끝부분을 잡고 면발이 2회 끊어질 때까지 늘렸다. 대조구의 우동면이 가장 길게 늘어났고 청어알 25, 청어알 12, 청어알1의 순이었다. 이는 글루텐 함량이 많을수록 길게 늘어나는 것으로 판단할 수 있다. 글루텐 함량은 <표 3>과 같다.Control group, Herring roe 1, Herring roe 12, Herring roe 25 Lactobacillus was added and the end of the udon noodles was added and the noodles were loosened until they were cut twice. The control noodles were the longest growing, followed by herring roe 25, herring roe 12 and herring roe 1. It can be judged that the longer the gluten content, the longer the increase. The gluten content is shown in Table 3.
글루텐의 분해율이 높으면 글루텐이 분해되어 면대 형성에 어려움이 있었다.When the rate of degradation of gluten is high, gluten is decomposed and it is difficult to form a surface layer.
<< 실시예Example 1>유산균1> lactic acid bacteria 발효된 반죽에 On fermented dough 트랜스글루타미나아제를Transglutaminase 첨가한 Added 후 면Rear face 제조 Produce
글루텐 분해율을 최대로 높이면 글루텐이 분해되어 면대 형성에 어려움이 있어 이를 보완하기 위하여 증점제, 검류, 당류 등의 첨가물을 첨가하여 우동면의 물성을 확인해 보았다.<표 4>는 대조구의 성분에 더하여 유산균 28.68%, 트랜스 글루타마나아제 0.36%, 키라기난 0.36%, 구아검 0.36%을 첨가한 것 및, 폴리글리시톨대조구에서 제거한 반죽에서의 글루텐 분해율을 보인다.Table 4 shows the addition of additives such as thickener, gum, and saccharide to check the properties of the noodles. Table 4 shows the addition of lactic acid bacteria 28.68%, transglutaminase 0.36%, chiraginan 0.36%, guar gum 0.36%, and the gluten breakdown in the dough removed from the polyglycitol control.
유산균 발효 배합과 당류인 폴리글리시톨 미첨가 배합을 비교해 보면 폴리글리시톨을 첨가한 배합에서 글루텐이 조금 더 분해됨을 알 수 있었다. 반면 카라기난과 구아검등의 검류를 첨가하였을 경우 분해율은 10%가량 낮게 측정되었다. Comparing lactic acid fermentation blend with polyglycitol - free blend of sugars, gluten was slightly degraded in blend containing polyglycitol. On the other hand, when carrageenan and guar gum were added, the degradation rate was measured to be as low as 10%.
또한 트랜스글루타미나아제 첨가 시 대조구 대비 글루텐 분해율이 소폭 상승했지만 이 정도의 분해율은 그 차이가 미미하다고 볼 수 있다.In addition, the addition of transglutaminase resulted in a slight increase in the degradation rate of gluten compared to the control.
<표 5>는 대조구의 성분에 더하여 유산균 28.68%, 트랜스 글루타마나아제 0.36%, 키라기난 0.36%, 구아검 0.36%을 첨가한 것 및, 폴리글리시톨 대조구에서 제거한 반죽에서의 물성측정 결과를 보여준다.Table 5 shows that the addition of lactic acid bacteria, 0.36% transglutamenase, 0.36% chlaguanan and 0.36% guar gum, in addition to the components of the control, and the measurement of physical properties in dough removed from polyglycitol control Lt; / RTI >
물성 측정 결과 모든 실험구에서 큰 차이를 보이지는 않았지만 경도(Hardness, %)는 구아검을 첨가한 실험구에서 가장 낮은 값을 보여 불음성에서 가장 좋은 수치를 얻었다. 반면 응집성(Cohesiveness)는 아주 근소한 차이를 보이며 각 실험구 별 쫄깃함의 정도는 큰 차가 없는 것으로 나타났다.Hardness (%) was the lowest value in the experimental group with guar gum, although the difference was not significant in all experimental groups. On the other hand, Cohesiveness showed very slight difference, and there was no significant difference in the degree of Kosi in each experiment.
씹힘성(chewiness, mJ)의 경우 카라기난을 첨가한 실험구에서 가장 낮은 수치를 보이며 끊김이 높게 나타나고 구아검을 첨가한 실험구의 값이 가장 높아 끊김이 적은 것으로 나타났다. 그러나 구아검 첨가 시 글루텐 분해율이 낮아져 글루텐 저감 면의 첨가물로써 적합하지 않았다.The chewiness (mJ) showed the lowest value in the experimental group added with carrageenan and the highest value in the experimental group added with guar gum. However, the addition of guar gum decreased the degradation rate of gluten and was not suitable as an additive for gluten reduced surface.
반면 트랜스글루타미나아제를 첨가한 제품이 대조구와 근사치를 나타냈고 면 제조 시 면대가 끊어지지 않아 좀 더 수월하게 제조할 수 있었다.On the other hand, the product added with transglutaminase exhibited an approximate value as the control, and the surface area was not cut off during the production of the cotton.
<< 실시예Example 2> 2> 다단압출방식에In multi-stage extrusion 의한 면 제조 Cotton fabrication by
다단압출방식을 위한 반죽의 성분비는 <표 6>에 나타내었다.The composition ratio of the dough for the multi-stage extrusion method is shown in Table 6.
트랜스글루타미나아제 및 유산균 상등액을 포함하지 않은 대조구와 본 발명에 따른 면을 압연 또는 압출방식을 사용하여 면을 제조한 후 경도,응집성 및 씹힘성을 조사하였고,그 결과를 <표 7>에 보인다.The control, without transglutaminase and lactic acid supernatant, and the surface of the present invention were examined for hardness, cohesiveness and chewiness after the surface was prepared by rolling or extrusion, and the results are shown in Table 7 .
측정 결과 경도(%)는 근소한 차이로 압출면이 가장 낮은 값을 보여 좋은 경도(%)를 보였다. 또 응집성의 값 역시 압출면이 가장 높은 값을 압연면은 가장 낮은 값을 보였다. 이는 압출면이 가장 쫄깃함을 나타낸다. 씹힘성 역시 압출면의 값이 가장 높아 끊김이 적은 것으로 나타났다. 위의 결과를 종합하였을 때, 압출면이 가장 좋은 결과를 보였다.As a result, the hardness (%) showed a small value and the hardness (%) of the extruded surface was the lowest. Also, cohesive values showed the highest values on the extruded surface and the lowest values on the rolled surface. This indicates that the extruded surface is the most sticky. The chewiness was also the highest value on the extruded surface, indicating that the cut was less. When the above results are combined, the extruded surface shows the best result.
Claims (5)
The gluten-free surface according to claim 1, wherein the amount of the culture supernatant of the lactic acid bacteria is 10.00 to 40.00% by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160130803A KR20180039464A (en) | 2016-10-10 | 2016-10-10 | Gluten-free noodle composition containing transglutaminase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160130803A KR20180039464A (en) | 2016-10-10 | 2016-10-10 | Gluten-free noodle composition containing transglutaminase |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20180039464A true KR20180039464A (en) | 2018-04-18 |
Family
ID=62082676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160130803A KR20180039464A (en) | 2016-10-10 | 2016-10-10 | Gluten-free noodle composition containing transglutaminase |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20180039464A (en) |
-
2016
- 2016-10-10 KR KR1020160130803A patent/KR20180039464A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101750154B1 (en) | Rice bread and rice fermented composition having superior effect of aging-retardation and manufacturing method thereof | |
Fusco et al. | The genus Weissella: taxonomy, ecology and biotechnological potential | |
Todorov et al. | Traditional cereal fermented foods as sources of functional microorganisms | |
Admassie | A review on food fermentation and the biotechnology of lactic acid bacteria | |
Palanisamy et al. | Enhancement of nutritional value of finger millet-based food (Indian dosa) by co-fermentation with horse gram flour | |
JP6312688B2 (en) | Microencapsulated bacterial population for gluten degradation into sourdough and method for producing the sourdough | |
Moghaddam et al. | Evaluating the effects of lactic acid bacteria and olive leaf extract on the quality of gluten-free bread | |
US10820599B2 (en) | Enzyme exhibiting fructan hydrolase activity | |
KR101526106B1 (en) | Method for producing fermented material of wheat bran with mucilage and GABA content using mixed fermentation and method for manufacturing cookie using fermented material of wheat bran | |
CA2811390C (en) | Method of production of fermented, pro-healthy, cereal beverages | |
Çakır et al. | The molecular and technological characterization of lactic acid bacteria in einkorn sourdough: Effect on bread quality | |
Font de Valdez et al. | New Trends in Cereal‐Based Products Using Lactic Acid Bacteria | |
Bartkiene et al. | Influence of diets to Wistar rats supplemented with soya, flaxseed and lupine products treated by lactofermentation to improve their gut health | |
KR20180039467A (en) | Gluten-free Noodlecomposition made by using multiple pressing out method | |
Guo et al. | Casein hydrolysate's effects on the fermentation properties, texture, and chemical characteristics and the bacterial microbiota of fermented glutinous rice dough | |
KR20180039464A (en) | Gluten-free noodle composition containing transglutaminase | |
KR20160062361A (en) | Barley bread of which expiration date is extended and process for preparing the same | |
KR100923051B1 (en) | Functional microorganism preparation and the bread using said microorganism preparation | |
KR20190142263A (en) | Lactobacillus plantarum MB-0601 strain having gluten degradation activity from salted seafood and uses thereof | |
Bhardwaj et al. | Asian fermented root and tuber-based products | |
EP4201211A1 (en) | Pasta sourdough cultures and methods of making same | |
US20230189825A1 (en) | Pasta sourdough cultures and methods of making same | |
KR20180079123A (en) | Mix composition of rice flour for bakery | |
Odutayo et al. | Characterization of potential probiotics isolated from fermented under-utilized Chrysophyllum albidum Linn kernels using microbiological, biochemical and molecular techniques | |
JP2023037331A (en) | Intestinal microflora-improving agent and oral composition for improving intestinal flora |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |